| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 103 | 426 | 41 | 101 | 7.715 |
| Total Income - EUR | - | - | - | - | 0 | 103 | 426 | 41 | 101 | 7.715 |
| Total Expenses - EUR | - | - | - | - | 0 | 1.859 | 7.235 | 7.376 | 23.048 | 40.952 |
| Gross Profit/Loss - EUR | - | - | - | - | 0 | -1.755 | -6.809 | -7.336 | -22.947 | -33.238 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | -1.758 | -6.822 | -7.337 | -22.948 | -33.238 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sano Medica Diagnostics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 42 | 134 | 969 | 93 | 2.321 | 2.977 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 3 | 10 | 34 | 64 | 1.679 |
| Cash | - | - | - | - | 42 | 131 | 959 | 59 | 2.257 | 1.298 |
| Shareholders Funds | - | - | - | - | 42 | -1.717 | -8.501 | -15.865 | -38.765 | -71.786 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 0 | 1.851 | 9.470 | 15.958 | 41.086 | 74.763 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Sano Medica Diagnostics S.r.l.